EHD2
Basic information
Region (hg38): 19:47713422-47743134
Previous symbols: [ "PAST2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EHD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 44 | 44 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 44 | 0 | 0 |
Variants in EHD2
This is a list of pathogenic ClinVar variants found in the EHD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-47716643-C-T | not specified | Uncertain significance (May 31, 2023) | ||
19-47716655-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
19-47716671-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
19-47716680-C-T | not specified | Uncertain significance (Oct 25, 2024) | ||
19-47716700-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
19-47716734-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
19-47716785-A-C | not specified | Uncertain significance (Feb 06, 2024) | ||
19-47716874-G-A | not specified | Uncertain significance (Nov 08, 2024) | ||
19-47716910-G-A | not specified | Uncertain significance (Dec 28, 2023) | ||
19-47716957-C-T | not specified | Likely benign (Feb 22, 2025) | ||
19-47716965-C-T | not specified | Uncertain significance (Feb 24, 2025) | ||
19-47716980-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
19-47716997-G-A | not specified | Uncertain significance (Dec 06, 2022) | ||
19-47718531-A-G | not specified | Uncertain significance (Mar 29, 2024) | ||
19-47718573-A-G | not specified | Uncertain significance (Sep 12, 2024) | ||
19-47718574-T-C | not specified | Uncertain significance (Dec 05, 2022) | ||
19-47718604-G-A | not specified | Uncertain significance (Jan 31, 2025) | ||
19-47725922-G-C | not specified | Uncertain significance (Jul 26, 2024) | ||
19-47725934-G-A | not specified | Uncertain significance (Apr 20, 2023) | ||
19-47726018-A-T | not specified | Uncertain significance (Jun 28, 2024) | ||
19-47726037-T-C | not specified | Uncertain significance (Jun 25, 2024) | ||
19-47726126-C-G | not specified | Uncertain significance (Jan 27, 2025) | ||
19-47726135-C-G | not specified | Uncertain significance (Apr 01, 2024) | ||
19-47736375-G-A | not specified | Uncertain significance (Apr 23, 2024) | ||
19-47736391-A-G | not specified | Uncertain significance (Apr 13, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EHD2 | protein_coding | protein_coding | ENST00000263277 | 5 | 29792 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.308 | 0.692 | 125743 | 0 | 5 | 125748 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.88 | 269 | 371 | 0.725 | 0.0000264 | 3495 |
Missense in Polyphen | 54 | 95.706 | 0.56423 | 940 | ||
Synonymous | 0.500 | 171 | 180 | 0.953 | 0.0000148 | 1101 |
Loss of Function | 2.92 | 4 | 17.0 | 0.235 | 7.85e-7 | 200 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000879 | 0.0000879 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000906 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000332 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: ATP- and membrane-binding protein that controls membrane reorganization/tubulation upon ATP hydrolysis (By similarity). Plays a role in membrane trafficking between the plasma membrane and endosomes (PubMed:17233914). Important for the internalization of GLUT4. Required for fusion of myoblasts to skeletal muscle myotubes. Required for normal translocation of FER1L5 to the plasma membrane (By similarity). Regulates the equilibrium between cell surface-associated and cell surface-dissociated caveolae by constraining caveolae at the cell membrane (PubMed:25588833). {ECO:0000250|UniProtKB:Q8BH64, ECO:0000269|PubMed:17233914, ECO:0000269|PubMed:25588833}.;
- Pathway
- Endocytosis - Homo sapiens (human);Insulin Signaling;Factors involved in megakaryocyte development and platelet production;Hemostasis
(Consensus)
Recessive Scores
- pRec
- 0.136
Intolerance Scores
- loftool
- 0.0710
- rvis_EVS
- -1.04
- rvis_percentile_EVS
- 7.77
Haploinsufficiency Scores
- pHI
- 0.149
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.659
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.913
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ehd2
- Phenotype
Gene ontology
- Biological process
- endocytosis;blood coagulation;cortical actin cytoskeleton organization;endocytic recycling;protein localization to plasma membrane;plasma membrane tubulation;positive regulation of myoblast fusion;positive regulation of endocytic recycling
- Cellular component
- nucleus;cytosol;plasma membrane;caveola;endosome membrane;microtubule cytoskeleton;extrinsic component of membrane;intercellular bridge;perinuclear region of cytoplasm;recycling endosome membrane;extracellular exosome
- Molecular function
- nucleic acid binding;calcium ion binding;protein binding;ATP binding;GTP binding;hydrolase activity;protein domain specific binding;identical protein binding